Company: TXG
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001628280-25-050332
Chunk: 71

Company: 10x Genomics, Inc.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 2
Chunk 71
---
20252024$%InstrumentsChromium$4,927 $7,641 $(2,714)(36)%$16,567 $24,283 $(7,716)(32)%Spatial7,072 11,415 (4,343)(38)24,744 44,078 (19,334)(44)Total instruments revenue11,999 19,056 (7,057)(37)41,311 68,361 (27,050)(40)ConsumablesChromium92,519 96,536 (4,017)(4)262,416 274,571 (12,155)(4)Spatial35,373 29,668 5,705 19 103,017 85,330 17,687 21 Total consumables revenue127,892 126,204 1,688 1 365,433 359,901 5,532 2 Services8,128 6,299 1,829 29 24,255 17,292 6,963 40 Products and services revenue148,019 151,559 (3,540)(2)430,999 445,554 (14,555)(3)License and royalty revenue983 95 888 935 45,794 210 45,584 21707 Total revenue$149,002 $151,654 $(2,652)(2)%$476,793 $445,764 $31,029 7 %

Products and services revenue decreased $3.5 million, or 2%, to $148.0 million for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. Instruments revenue decreased $7.1 million, or 37%, to $12.0 million for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. Consumables revenue increased $1.7 million, or 1%, to $127.9 million for the three months ended September 30, 2025 as compared to the three months ended September 30, 2024. Services revenue increased $1.8 million, or 29%, to $8.1 million for the three months ended September 30, 2025 as compared to three months ended September 30,